A. N. Slepushkin

481 total citations
20 papers, 391 citations indexed

About

A. N. Slepushkin is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, A. N. Slepushkin has authored 20 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 5 papers in Infectious Diseases and 3 papers in Microbiology. Recurrent topics in A. N. Slepushkin's work include Influenza Virus Research Studies (16 papers), Respiratory viral infections research (9 papers) and Pediatric health and respiratory diseases (3 papers). A. N. Slepushkin is often cited by papers focused on Influenza Virus Research Studies (16 papers), Respiratory viral infections research (9 papers) and Pediatric health and respiratory diseases (3 papers). A. N. Slepushkin collaborates with scholars based in Russia, United Kingdom and United States. A. N. Slepushkin's co-authors include Burtseva Ei, Alan P. Kendal, G. I. Alexandrova, Larisa Rudenko, Elena Grigorieva, Nancy J. Cox, Andrey Rekstin, Arnold S. Monto, Y. Z. Ghendon and Gregory A. Tannock and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Journal of Medical Virology.

In The Last Decade

A. N. Slepushkin

19 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. N. Slepushkin Russia 9 330 132 58 42 41 20 391
Tracy Chan Canada 11 503 1.5× 126 1.0× 87 1.5× 63 1.5× 71 1.7× 17 583
Susan C. Wood France 14 188 0.6× 82 0.6× 17 0.3× 11 0.3× 141 3.4× 19 432
Michael Lu United States 6 282 0.9× 93 0.7× 23 0.4× 17 0.4× 30 0.7× 7 308
Yu Cong United States 11 167 0.5× 258 2.0× 26 0.4× 17 0.4× 61 1.5× 18 373
J Rankin United States 8 125 0.4× 100 0.8× 21 0.4× 17 0.4× 59 1.4× 12 249
Samuel Nyamweya Gambia 6 107 0.3× 98 0.7× 95 1.6× 3 0.1× 69 1.7× 7 296
Rie Ogawa Japan 9 340 1.0× 114 0.9× 60 1.0× 19 0.5× 76 1.9× 10 422
Mitsutaka Kitano Japan 12 472 1.4× 182 1.4× 133 2.3× 55 1.3× 101 2.5× 23 608
Steve Gamblin United Kingdom 4 191 0.6× 43 0.3× 48 0.8× 22 0.5× 92 2.2× 4 228
Hideka Miura Japan 11 294 0.9× 266 2.0× 117 2.0× 21 0.5× 121 3.0× 22 597

Countries citing papers authored by A. N. Slepushkin

Since Specialization
Citations

This map shows the geographic impact of A. N. Slepushkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. N. Slepushkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. N. Slepushkin more than expected).

Fields of papers citing papers by A. N. Slepushkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. N. Slepushkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. N. Slepushkin. The network helps show where A. N. Slepushkin may publish in the future.

Co-authorship network of co-authors of A. N. Slepushkin

This figure shows the co-authorship network connecting the top 25 collaborators of A. N. Slepushkin. A scholar is included among the top collaborators of A. N. Slepushkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. N. Slepushkin. A. N. Slepushkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ei, Burtseva, Philip Ellery, Glenn A. Marsh, et al.. (2011). Antiviral activity of arbidol, a broad‐spectrum drug for use against respiratory viruses, varies according to test conditions. Journal of Medical Virology. 84(1). 170–181. 75 indexed citations
2.
Ei, Burtseva, et al.. (2007). [Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].. PubMed. 52(2). 24–9. 9 indexed citations
3.
Slepushkin, A. N., et al.. (2004). Influenza morbidity and some peculiarities of antiinfluenza immunity and prevention during influenza pandemics. International Congress Series. 1263. 787–790. 2 indexed citations
4.
Ei, Burtseva, et al.. (2004). [Influenza viruses which preconditioned the epidemic rise in Russia in 2002-2003. A resumed circulation of influenza viruses similar to V/Victoria/2/87].. PubMed. 49(3). 12–7.
5.
Колобухина, Л. В., et al.. (2000). Changeability and dissemination of influenza A virus (H1N1) between 1990 and 1998.. Problems of Virology. 45(5). 18–22. 1 indexed citations
6.
Ei, Burtseva, et al.. (2000). Grippol: An effective vaccine for immunization of the elderly against influenza. Immunologiya. 2. 39–42. 2 indexed citations
7.
Ei, Burtseva, et al.. (1996). [Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children].. PubMed. 34–7. 6 indexed citations
8.
Dk, L'vov, Shchelkanov MIu, P. G. Deryabin, et al.. (1994). Vibrotactile Perception: Perspective Taking by Children Who Are Visually Impaired.. Journal of Visual Impairment & Blindness. 51(1). 11–4. 21 indexed citations
9.
Hemphill, Mark L., et al.. (1993). Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987–91. Epidemiology and Infection. 111(3). 539–546. 7 indexed citations
10.
Rudenko, Larisa, A. N. Slepushkin, Arnold S. Monto, et al.. (1993). Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Schoolchildren and Their Unvaccinated Contacts in Novgorod, Russia. The Journal of Infectious Diseases. 168(4). 881–887. 149 indexed citations
11.
Slepushkin, A. N., Burtseva Ei, Larisa Rudenko, et al.. (1993). Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine. 11(3). 323–328. 23 indexed citations
12.
Ei, Burtseva, et al.. (1992). [The protective action of arbidol during a rise in respiratory diseases in 1990].. PubMed. 36(5). 380–1. 5 indexed citations
14.
Slepushkin, A. N., et al.. (1989). [The 30th anniversary of the adoption by the World Health Organization of the program for smallpox eradication throughout the world].. PubMed. 33(5). 517–23. 1 indexed citations
16.
Slepushkin, A. N., et al.. (1984). Results of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs.. PubMed. 62(1). 75–82. 2 indexed citations
17.
Oxford, John, Lars R. Haaheim, A. N. Slepushkin, et al.. (1981). Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. Journal of Hygiene. 86(1). 17–26. 29 indexed citations
18.
Tyrrell, D. A. J., et al.. (1973). Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection. Postgraduate Medical Journal. 49(569). 200–202. 3 indexed citations
19.
Slepushkin, A. N., G. C. Schild, A. S. Beare, S Chinn, & D. A. J. Tyrrell. (1971). Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. Epidemiology and Infection. 69(4). 571–578. 28 indexed citations
20.
Slepushkin, A. N.. (1959). An Epi^emiologfe'cal Study of Laboratory Infections with Venezuelan Equine Encephalomyelitis.. 4(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026